熱門資訊> 正文

Coeptis Therapeutics重新与纳斯达克合规

2024-09-19 19:47

Coeptis Therapeutics (NASDAQ:COEP) said it has received a notification letter from the Nasdaq panel, granting its request for continued listing on the Nasdaq.
The request was granted after the company regained compliance with Nasdaq's listing rules.

More on Coeptis Therapeutics Holdings, Inc.

Seeking Alpha’s Quant Rating on Coeptis Therapeutics Holdings, Inc.
Financial information for Coeptis Therapeutics Holdings, Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。